Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

Authors not listed

Neil M Rofsky, MD, MHA · 2019

Dysbiosis Human Randomized controlled trial

Abstract

The investigators will conduct tau positron emission tomography (PET) scans on 125 adults using the radiopharmaceutical Flortaucipir F18 (\[18F\]AV-1451). This will allow the investigators to determine tau deposition across adults of different ages and assess the relationship of current tau burden to cognitive function and amyloid deposition collected over the previous 10-year interval.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-13 MST

Cite this

APA

Anonymous. (2019). Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study. <em>Neil M Rofsky, MD, MHA</em>. https://clinicaltrials.gov/study/NCT04080544

Vancouver

Anonymous. Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study. Neil M Rofsky, MD, MHA. 2019.

BibTeX

@misc{anon2019Causeo, title = {Cause or Effect: Untangling the Relationship With Amyloid and Tau Deposits to Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study}, author = {Anonymous}, journal = {Neil M Rofsky, MD, MHA}, year = {2019}, }